About Us
Powering next-generation biotech solutions
Providing scalable platforms and R&D partnerships across industry
1
Licensing
& platform access
Recurring revenues with the first EVis NanoVector platform and research services and R&D partnerships to conduct studies on behalf of partners.
2
R&D collaborations
Technology licensing program that allows laboratories and pharmaceutical companies to access our hybrid technology to load RNA into EVs and develop targeted, gene- delivery therapies.
3
Therapeutic development
Developing proprietary therapeutic programs with the goal of achieving the end of preclinical studies.
Innovative Gene Therapy Solutions
We offer hybrid platforms based on extracellular vesicles and lipid nanoparticles for delivering therapeutic nucleic acids
JOIN THE INNOVATION
Don’t miss out on our exciting journey!
Follow us on LinkedIn for all the latest updates and exclusive content.